199 related articles for article (PubMed ID: 2904162)
1. [Serum level of tumor markers (antigen Ca 19-9, CEA, ferritin) in digestive tumors. Their diagnostic usefulness].
Jovin G; Stănel I; Popovici I; Oproiu A
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(3):223-9. PubMed ID: 2904162
[No Abstract] [Full Text] [Related]
2. [Diagnostic value of a new serum marker of human digestive cancer: the carbohydrate antigen 19.9; comparison with the carcinoembryonic antigen].
Olsson NO; Crimet-Montange D; Martin F
Gastroenterol Clin Biol; 1985 Mar; 9(3):206-11. PubMed ID: 3859449
[TBL] [Abstract][Full Text] [Related]
3. Role of local and systemic factors in increasing serum glycoprotein markers of pancreatic cancer.
Fabris C; Basso D; Piccoli A; Meggiato T; Del Favero G; Fogar P; Panozzo MP; Faggian D; Vianello D; Plebani M
J Med; 1991; 22(3):145-56. PubMed ID: 1770322
[TBL] [Abstract][Full Text] [Related]
4. [Clinical evaluation of serum TAC-41 in various digestive cancers].
Sato S; Yamanaka T; Kimura K
Rinsho Byori; 1989 Nov; 37(11):1259-62. PubMed ID: 2601083
[TBL] [Abstract][Full Text] [Related]
5. [Clinical evaluation of the efficacy of the combined determination of serum markers CEA, CA 19.9, CA 72.4 as indexes of gastro-intestinal tract neoplasms].
Marchei P; Cifaldi L; De Benedetto A; Santini D; Manna A; Trasatti L; Marchei GG; Reale MG
G Ital Oncol; 1990; 10(4):121-4. PubMed ID: 2093080
[TBL] [Abstract][Full Text] [Related]
6. The usefulness of serum levels of CEA, CA 50, and ferritin in the management of renal cell cancer.
Kokociñska D; Rajchel K; Nalewajka E; Zagalski K
J Environ Pathol Toxicol Oncol; 1996; 15(2-4):279-81. PubMed ID: 9216822
[TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of a combination assay of CEA, CA-19-9 and TPA in patients with colorectal cancer].
Nishida O; Shiroto H; Satoh N; Nakajima Y; Manabe K; Kondoh Y; Sano F; Uchino J
Gan No Rinsho; 1988 Aug; 34(9):1096-100. PubMed ID: 3172515
[TBL] [Abstract][Full Text] [Related]
8. [Radioimmunological determination of tumor markers in the diagnosis of recurrences of rectal cancer].
Ozhiganov EL; Kuznetsova LF
Med Radiol (Mosk); 1991; 36(10):17-20. PubMed ID: 1719331
[TBL] [Abstract][Full Text] [Related]
9. [Study on the clinical usefulness of NCC-ST-439 in cases of digestive tract cancer].
Anzai K; Kurihara M; Izumi T
Nihon Gan Chiryo Gakkai Shi; 1990 Jul; 25(7):1437-47. PubMed ID: 2212836
[TBL] [Abstract][Full Text] [Related]
10. [Monoclonal antibodies. Their usefulness in the diagnosis of malignant tumors of the digestive system].
Campos Campos F; Romero Navarro MA; Gutiérrez Samperio C; Esquivel P; Gaviño Chapa JF
Rev Gastroenterol Mex; 1989; 54(4):193-8. PubMed ID: 2616981
[TBL] [Abstract][Full Text] [Related]
11. [Antigens CA-50 and CA-242 in digestive tract and thyroid neoplasms].
Pomorski L; Pasieka Z; Kołomecki K; Czyz W; Kołodziejczyk M; Wróbel B
Wiad Lek; 1997; 50 Suppl 1 Pt 1():18-20. PubMed ID: 9446350
[TBL] [Abstract][Full Text] [Related]
12. [Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis].
Lorenz M; Happ J; Hottenrott C; Maul FD; Baum RP; Hör G; Encke A
Nuklearmedizin; 1986 Feb; 25(1):9-14. PubMed ID: 3459133
[TBL] [Abstract][Full Text] [Related]
13. [Fundamental and clinical evaluation of immunoradiometric assay (IRMA) for serum pancreatic oncofetal antigen (POA)].
Ohba N; Hashimoto T; Nishibu M; Kashiwaya Y; Kawai K; Matsubara F; Miyazaki I
Rinsho Byori; 1989 Feb; 37(2):153-8. PubMed ID: 2733181
[No Abstract] [Full Text] [Related]
14. The evaluation of tumor markers levels in determination of surgical procedure in patients with gallbladder carcinoma.
Stefanović D; Novaković R; Perisić-Savić M; Djordjević Z; Zivanović M; Stajić S
Med Pregl; 1993; 46 Suppl 1():58-9. PubMed ID: 8569609
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic value of tumor markers in the follow up of malignant neoplasms of the head and neck].
Grandis S; Screm MC; Cartei G
Acta Otorhinolaryngol Ital; 1989; 9(6):599-604. PubMed ID: 2699147
[TBL] [Abstract][Full Text] [Related]
16. Limits of CEA and ferritin in the diagnosis of pancreatic cancer.
Plebani M; Fabris C; Basso D; Del Favero G; Angonese C; Leandro G; Di Mario F; Burlina A; Naccarato R
Int J Pancreatol; 1988; 3 Suppl 1():S113-7. PubMed ID: 3209864
[TBL] [Abstract][Full Text] [Related]
17. [Immunohistochemical evaluation of several tumor markers (CEA, ferritin, Ca) and their correlation with estro-progestin receptor state in neoplasms].
Forti E; Wolf D; Melia M
Pathologica; 1985; 77(1049):241-9. PubMed ID: 3913892
[No Abstract] [Full Text] [Related]
18. [The existence of a correlation between the serum values of MCA and CA 15.3 in patients with digestive tumors].
Roiz MC; Vizoso F; Allende MT; Ruibal A
Rev Clin Esp; 1990 Nov; 187(7):376. PubMed ID: 2091127
[No Abstract] [Full Text] [Related]
19. [The value of tumor markers in colorectal cancer].
Peters KM; Grundmann R
Leber Magen Darm; 1989 Jan; 19(1):18-25. PubMed ID: 2927234
[TBL] [Abstract][Full Text] [Related]
20. Comparative effectiveness of the tumour diagnostics, CA 19-9, CA 125 and carcinoembryonic antigen in patients with diseases of the digestive system.
Sakamoto K; Haga Y; Yoshimura R; Egami H; Yokoyama Y; Akagi M
Gut; 1987 Mar; 28(3):323-9. PubMed ID: 3471687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]